Summary of an observational study comparing the efficacy and safety of rivaroxaban, apixaban, and dabigatran in patients with atrial fibrillation
Currently, stroke prevention and systemic thromboembolism prevention using anticoagulants is one of the three important pillars in the strategy for managing atrial fibrillation. Among these, direct-acting oral anticoagul...